Profil
Mr. David Szeto is an Associate at Deep Track Capital LP.
He has over a decade of experience in the biotech/pharma industry.
Prior to joining Deep Track, he was a Senior Analyst at Great Point Partners.
Earlier in his career, he held roles across the ecosystem - ranging from sell-side equity research at the RBC to business development at Bayer and public health strategy at the FDA.
He received his graduate degree from the University of California San Diego.
Postes actifs de David Szeto
| Sociétés | Poste | Début |
|---|---|---|
Deep Track Capital LP
Deep Track Capital LP Investment ManagersFinance Provides investment advice | Analyst-Equity | - |
Anciens postes connus de David Szeto
| Sociétés | Poste | Fin |
|---|---|---|
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/09/2021 |
Great Point Partners LLC
Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Analyst-Equity | - |
Formation de David Szeto
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Great Point Partners LLC
Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Deep Track Capital LP
Deep Track Capital LP Investment ManagersFinance Provides investment advice | Finance |
















